Here is another one of those interesting issues that I frankly have never thought much about. That is, how well or poorly does the biopharma industry deal with LGBTQ+ issues in comparison to other environments.
Check this out. What you will see is a fascinating series of observations and recommendations on this topic. Overall, this piece notes, less than 50% of LGBTQ+ employees are “out” at their place of work. BUT. For our industry, the good news is that our companies are heavy in PhDs, MDs and other educated professionals, who tend to be more accepting of alternative lifestyles. AND. Our companies also tend to be located in or near big cities, with urbanites being more accepting of differences in sexual orientation than rurals.
Arguably, the bad news is that most biopharma companies do not have special programs or initiatives to reach out to LGBTQ+ consumers, although companies like GSK are beginning to move in this direction.
An important point is made in this article with the observation that not all of the letters in the LGBTQ+ acronym have the same issues. Transgender employees who transition while on the job, it is noted, require that other employees also transition. Translated, if the boss that used to use the men’s room suddenly transitions to using the ladies’ room, some eyebrows will likely furrow and tongues wag.
Bottom Line. At the end of the day, the executives interviewed for this article were largely unanimous in recommending that members of the LGBTQ+ community speak their “own truth” in the workplace setting. Backing down on issues related to sexual orientation is likely to be deleterious to both the employee and to the gay community at large.
Moreover, HIV/AIDS is not the only market where members of the LGBTQ+ community constitute a significant, and significantly different, market segment. Product managers need to decide if their product offers special benefits to this community, and target and tailor their promotional messages accordingly.
All interesting issues. How does your company rate? What should it be doing differently as we move into 2022???